Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aschele

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to 5-fluorouracil in advanced colorectal cancerO Belvedere, F Puglisi, C Di Loreto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracilA Mori, S Bertoglio, A Guglielmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Schedule-dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitroC Aschele, C Baldo, A F Sobrero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 21, 2014
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-upR Glynne-Jones, P J Nilsson, C Aschele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapyC Aschele, D Debernardis, S Casazza, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas)E Bolli, S Saccomanno, G Mondini, et al.
Journal of the National Cancer Institute|December 1, 1993
Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cellsA F Sobrero, C Aschele, A P Guglielmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cellsA Guglielmi, C Aschele, A Mori, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancerA Sobrero, M T Nobile, A Guglielmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracilS Cascinu, C Aschele, S Barni, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to 5-fluorouracil in advanced colorectal cancerO Belvedere, F Puglisi, C Di Loreto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracilA Mori, S Bertoglio, A Guglielmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Schedule-dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitroC Aschele, C Baldo, A F Sobrero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 21, 2014
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-upR Glynne-Jones, P J Nilsson, C Aschele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapyC Aschele, D Debernardis, S Casazza, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas)E Bolli, S Saccomanno, G Mondini, et al.
Journal of the National Cancer Institute|December 1, 1993
Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cellsA F Sobrero, C Aschele, A P Guglielmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cellsA Guglielmi, C Aschele, A Mori, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancerA Sobrero, M T Nobile, A Guglielmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracilS Cascinu, C Aschele, S Barni, et al.
Pageof 4